DCF — WYOMING MEDICAL CENTER
Enterprise Value: $-128.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-128.3M
Enterprise Value
$-45.8M
PV of Cash Flows
$-82.5M
PV of Terminal Value
$-132.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $234.8M | $-5.2M | -2.0% | $-15.1M | $-13.7M |
| Year 2 | $241.8M | $-2.9M | -1.0% | $-13.1M | $-10.9M |
| Year 3 | $249.1M | $-0.5M | -0.0% | $-11.0M | $-8.3M |
| Year 4 | $256.5M | $0.8M | 0.0% | $-10.1M | $-6.9M |
| Year 5 | $264.2M | $1.5M | 1.0% | $-9.7M | $-6.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-128.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$227.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.026962214517578312
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5